본문 바로가기

Healthcare Utilization and Treatment Patterns in Diabetic Macular Edema in Korea: a Retrospective Chart Review

문서 유형
연구출판물 · 리뷰논문
등재
KCISCIEScopus
저널 순위
JCR Q2Scopus Q1
피인용
Web of Science 8Scopus 12KCI 2
FWCI (Scopus)
1.06
JCR IF
JCR 2018 1.716
ISSN
1011-8934

저자

  1. Park, Kyu Hyung제1저자Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea
  2. Kim, Yun YoungDepartment of Ophthalmology, Daegu Catholic University Medical Center, Daegu, South Korea
  3. Jo, Young JoonDepartment of Ophthalmology, Chungnam National University Hospital, Daejeon, South Korea
  4. Oh, JaeryungDepartment of Ophthalmology, Korea University Anam Hospital, Seoul, South Korea
  5. Lee, Joo EunJ Eye Center, Busan, South Korea
  6. 이지은Department of Ophthalmology, Pusan National University Hospital, Busan, South Korea
  7. Park, Dong HoDepartment of Ophthalmology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, South Korea
  8. Kang, Se WoongDepartment of Ophthalmology, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, South Korea
  9. Lee, Won KiDepartment of Ophthalmology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea
  10. Kim, Ha KyoungDepartment of Ophthalmology, Hallym University Kangnam Sacred Heart Hospital, Seoul, South Korea
  11. Adena, MichaelDatalytics Pty Ltd, Canberra, Australia
  12. Tan, JonathanAllergan Singapore Pte. Ltd, Singapore
  13. Kim, Si Dong교신저자Department of Ophthalmology, Daegu Catholic University Medical Center, Daegu, South Korea

초록

Background: Limited data exist on real-world treatment patterns for diabetic macular edema (DME) in Korea. In this study, we investigated DME treatment patterns from 2009 to 2014 and the impact of baseline treatment on healthcare resource utilization and visual acuity (VA) outcomes. Methods: A retrospective cohort chart review of DME patients treated at 11 hospital ophthalmology clinics between January 1, 2012 and December 31, 2013 was conducted. We collected data on demographics, healthcare resource utilization (clinic visits, treatment visits, and visits for ocular investigations), distribution of DME treatments, and VA. Results: Overall, 522 DME patients (men, 55.2%; mean age, 59 years; mean HbA1c [n = 209], 8.4%) with 842 DME eyes were evaluated. For all treatments, healthcare resource utilization was significantly higher during the first 6 months versus months 7-12, year 2, or year 3 (P <= 0.001), but was highest for patients whose first treatment was an anti-vascular endothelial growth factor (VEGF) treatment (visits/quarter; anti-VEGF, 1.9; corticosteroids, 1.7; laser, 1.4). Use of macular laser therapy decreased (44% to 8%), whereas use of anti-VEGF injections increased (44% to 69%) during the study period. However, VA improvement was not commensurate with healthcare resource utilization of anti-VEGF treatment (mean VA gain, 2.7 letters). Conclusion: A trend toward increasing use of intravitreal anti-VEGF injections for DME treatment was observed in Korea. However, the frequency of dosing and monitoring was lower in clinical practice versus major clinical trials, which may have led to the less-than-favorable improvements in visual outcomes.

키워드

Anti-VEGFClinical Practice PatternsIntravitreal InjectionsLaser TherapyVisual AcuityVisual OutcomesENDOTHELIAL GROWTH-FACTORRANIBIZUMAB PLUS PROMPTDEFERRED LASERINTRAVITREAL DEXAMETHASONENATIONAL-HEALTHRISK-FACTORSRESOURCE USEREAL-WORLDRETINOPATHYTRIAL

식별자

Scopus EID
2-s2.0-85065076867
WoS UID
000465100600002
KCI
ART002457996